Pt # Age Stage Grade Histopathology Surgery Therapy Comment 1 66 III 2 Adenocaserous EL TC VI No response 2 54 III 3 Adenocarcinoma undifferentiated EL TCVI, Topotecan III No response 3 52 IIIB 3 Adenocaserous TAH, BSO, OM TC III Response 4 51 Ic 3 Adenocaserous TAH, BSO, OM TC III Response 5 58 III 3 Adenocapapillaraeendometroides TAH, BSO, OM TC VI, Topotecan III No response 6 51 IIIA 3 Carcinoma undifferentiated TAH, BSO, OM TC VI No response 7 67 IIIB 2 Adenocaserous TAH, BSO TC VI Topotecan III Response 8 65 III 3 Adenocaserous EL TC III Response 9 56 Ic 2 Adenocaserous TAH, BSO, OM TC VI Response 10 49 Ic 3 Adenocaendometroides TAH, BSO, OM TC VI Response 11 57 Ic 2 Adenocaendometroides TAH, BSO, OM TC VI Response 12 53 III 2 Adenocaserous TAH, BSO, OM TC VI Response Abbreviations: EL: Exploratory Laparotomy; TAH: Total Abdominal Hysterectomy; BSO: Bilateral Salpingoophorectomy; OM: Omentectomy; TK: Taxol + carbopaltin

Table 1: Characteristics of twelve OvCa patients for whom follow up clinical data were available.

Goto home»